Jazzy!

Data pipelining and workflow tools provider Accelrys has announced the licensing of its enterprise technology, Pipeline Pilot, to Jazz Pharmaceuticals, Inc. Pipeline Pilot, from the SciTegic division of Accelrys, seeks to provide Jazz Pharmaceuticals with a flexible and scalable platform to develop a full-featured sales force automation tool and a robust sales reporting architecture. Jazz Pharmaceuticals will also use the platform to integrate applications that process clinical and life sciences data.

With the implementation, Jazz hopes to use the solution in combination with mobile devices, getting on-demand access to sales and contact information at their fingertips. "Obtaining reports from disparate databases has never been easier than with the tools we are able to build using Pipeline Pilot," said Eric Mosbrooker, Commercial Analytics at Jazz Pharmaceuticals director, and clearly a happy customer. Palo Alto, Calif.-based Jazz Pharmaceuticals is focused on helping meet unmet medical needs in neurology and psychiatry with therapeutic products. Jazz Pharmaceuticals is currently aggressively building its product portfolio through commercialization and development activities.

Jazz works closely with patients, patient advocacy groups and healthcare professionals. Accelrys, Inc. is a leading provider of software for computation, simulation, and the management and mining of scientific data used by biologists, chemists and materials scientists, including nanotechnology researchers, for product design, drug discovery and development. SciTegic, Inc., a division of Accelrys, has pioneered "data pipelining" to process research discovery data with unprecedented flexibility. The company is headquartered in San Diego; its materials research and development team is based at its European Headquarters and Centre of Excellence in Cambridge, UK.